Canaccord Reiterates Buy Rating on Artivion Inc. (AORT)
Reiteration supports upside potential.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Reiteration supports upside potential.
What happened, with direct paths to the underlying reporting
Canaccord Genuity reiterates Buy; target $36; price $21.07.
Target: $36
Posted price: $21.07
Analyst firm: Canaccord Genuity
Analyst: William Plovanic
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.